MDCL Insider Trading Activity and SEC Form 4 Filings
MDCL insider trading summary
No open-market insider purchases or sales of Medicine Man Technologies, Inc. (MDCL) have been reported on SEC Form 4 in the past 12 months.
Latest MDCL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 20, 2020 | Justin Dye | Chief Executive Officer | Buy | $375K (187,500 @ $2.00) |
| Jun 19, 2019 | Paul Dickman | Director | Sell | $20K (5,090 @ $3.91) |
| Jun 18, 2019 | Paul Dickman | Director | Sell | $292K (74,465 @ $3.92) |
| Jun 17, 2019 | Paul Dickman | Director | Sell | $40K (10,192 @ $3.95) |
| Jun 16, 2019 | Justin Dye | Director | Buy | $7.0M (3,500,000 @ $2.00) |
| Jun 5, 2019 | Justin Dye | Director | Buy | $3.0M (1,500,000 @ $2.00) |
| Mar 28, 2019 | Charles N. Haupt | Director | Sell | $25K (20,000 @ $1.25) |
| Mar 28, 2019 | Charles N. Haupt | Director | Sell | $38K (30,000 @ $1.25) |
| Mar 26, 2019 | Jonathan Sandberg | Chief Financial Officer | Sell | $94K (45,500 @ $2.06) |
| Mar 25, 2019 | Jonathan Sandberg | Chief Financial Officer | Sell | $27K (13,000 @ $2.04) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.